Niagen Bioscience, Inc. Income Statement

Income Statement Jan2011 Dec2011 Dec2012 Jan2015 Jan2016 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 7.57M8.11M11.61M15.31M17.88M21.66M21.20M31.56M46.29M59.26M67.45M72.05M83.57M99.60M
Cost of Revenue 4.62M5.64M9.34M9.99M10.35M11.27M10.72M16.54M20.52M23.98M28.35M29.25M32.79M38.01M
Gross Profit 2.94M2.47M2.28M5.33M7.53M10.39M10.48M16.05M25.77M35.27M41.49M42.80M50.78M61.59M
Operating items
Research & Development 0.51M0.89M2.52M4.01M5.48M4.42M3.42M3.83M4.83M4.96M6.02M
Selling, General & Administrative 3.88M7.80M8.39M7.86M7.20M9.21M17.64M27.14M34.31M30.77M36.38M28.29M24.98M18.38M
Other Operating Expenses 1.09M2.54M5.52M2.18M1.51M1.56M5.47M16.61M18.34M20.95M28.35M28.31M26.44M29.47M
Operating Expenses 4.96M10.34M13.91M10.56M9.60M13.30M26.85M49.23M57.07M55.13M68.56M61.42M56.38M53.86M
Operating Income -2.02M-7.86M-11.64M-5.23M-2.07M-2.91M-16.38M-33.17M-31.30M-19.85M-27.07M-18.63M-5.60M7.73M
EBIT -2.02M-7.86M-11.64M-5.23M-2.07M-2.91M-16.38M-33.17M-31.30M-19.85M-27.07M-18.63M-5.60M7.73M
Non-operating items
Interest & Investment Income 0.00M0.00M0.00M0.00M0.00M0.00M0.66M1.13M
Other Non Operating Income -0.31M-0.07M
Non Operating Income -0.03M-0.03M-0.03M-0.16M-0.57M-0.65M0.75M-0.14M-0.85M
Net income details
EBT -2.05M-7.83M-11.60M-5.39M-2.63M-3.55M-16.53M-33.25M-32.15M-19.93M-27.13M-18.63M-4.94M8.86M
Tax Provisions -0.00M0.30M
Profit After Tax -2.05M-7.89M-11.66M-5.39M-2.77M-3.55M-16.53M-33.32M-32.15M-19.93M-27.13M-16.54M-4.94M8.60M
Income from Continuing Operations -2.05M-7.83M-11.60M-5.39M-2.63M-3.55M-16.53M-33.25M-32.15M-19.93M-27.13M-18.63M-4.94M8.55M
Consolidated Net Income -2.05M-7.83M-11.60M-5.39M-0.13M0.62M5.15M-33.25M-32.15M-19.93M-27.13M-18.63M-4.94M8.55M
Income towards Parent Company -2.05M-7.83M-11.60M-5.39M-0.13M0.62M5.15M-33.25M-32.15M-19.93M-27.13M-18.63M-4.94M8.55M
Net Income towards Common Stockholders -2.05M-7.83M-11.60M-5.39M-0.13M0.62M5.15M-33.25M-32.15M-19.93M-27.13M-18.63M-4.94M8.55M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 20.05M24.87M30.88M35.64M36.37M37.90M48.19M55.10M59.58M61.79M68.29M74.47M75.12M76.38M
Shares Outstanding (Diluted Average) 48.25M68.31M61.07M67.19M69.73M74.98M78.12M
EBITDA -2.02M-7.86M-11.64M-5.23M-2.07M-2.91M-16.38M-33.17M-31.30M-19.85M-27.07M-18.63M-5.60M7.73M
Tax Rate 0.17%3.44%